|
Recent Developments |
|
22-JUN-10
Aarti Drugs, is a part of the Rs 12.65 billion Aarti Group, announced that its plant situated at GIDC Sarigam, Valsad district has been closed pursuant to direction received from Gujarat Pollution Control Board (GPCB).
09-APR-10
Fairwealth Securities, a leading broking firm has recommended to `Buy` Aarti Drugs (ADL) for a target price of Rs 130-135 against current market price (CMP) of Rs 104 for a investment period of 6-12 months, ... More.. |
| Business Profile |
Future Plans |
|
|
|
|
One To One
|
|
Recent news
|
|
|
| Brief Financials (in Rs. Mn.) | |
| Period ending (months) | 31-Dec-2014(9) | 31-Mar-2014 (12) | 31-Mar-2013 (12) | | Net sales | 96.70 | 176.10 | 260.50 | | Other Income | 12.20 | 15.50 | 14.80 | | Total Income | 108.90 | 191.60 | 275.30 | | Cost of goods sold | 131.60 | 167.50 | 222.80 | | OPBDIT | -22.70 | 24.10 | 52.50 | | PAT | -27.30 | 13.90 | 46.10 | | Gross Block | - | - | - | | Equity capital | 100.30 | 100.30 | 100.30 | | EPS (Rs.) | - | 0.69 | 2.30 | | DPS (Rs.) | - | - | - | | BV (Rs.) | - | - | - | | P/E range (x) | - | 3.59 - 6.52 | 1.30 - 2.84 | | Debt / Equity (x) | - | - | - | | Operating margin (% of OI) | -20.8 | 12.6 | 19.1 | | Net margin (% of OI) | -25.1 | 7.3 | 16.7 |
|
|
Detailed Financials
|
|
|
|
|
